Increased risk of adverse pregnancy outcomes among women affected by herpangina




Objective


This population-based study aimed to assess the relation between herpangina and adverse pregnancy outcomes: low birthweight (LBW), small for gestational age (SGA), and preterm delivery.


Study Design


A total of 242 pregnant women who had singleton births and who visited ambulatory care centers for the treatment of herpangina were assessed, together with 1936 matched women as a comparison group. Conditional logistic regression analyses were performed to examine the risk of LBW, preterm birth, and SGA for mothers with herpangina and unaffected mothers.


Results


Compared with pregnant women without herpangina, herpangina was associated with a 2.29- (95% confidence interval [CI], 1.42–3.69), 1.67- (95% CI, 1.04–2.68), and 1.63-fold (95% CI, 1.14–2.33) increased risk of having LBW, preterm, and SGA infants, respectively, after adjusting for family income and maternal and infant characteristics.


Conclusion


Our findings highlight a significant potential risk posed by herpangina, a usually mild disease, among pregnant women.


Herpangina is a common enteroviral infection associated with a wide range of clinical manifestations. Because common enteroviral infections are mild, most affected patients can recover by themselves without specific medical treatment. However, enterovirus 71 can cause serious central nervous system and cardiopulmonary complications, with a fatality rate of approximately 26%. Severe outbreaks of herpangina have been reported in many Asian countries.


Herpangina usually occurs in very young children (<4 years), with peak incidence appearing at 1 year of age. Adults have a much lower rate of infection, milder clinical manifestations, and fewer adverse sequelae. Usually primary cases develop in children and spread horizontally to siblings and parents. Pregnant women are at higher risk of being infected, probably because mothers are usually the primary caregivers for infected young children. Existing literature suggests that when women are infected during pregnancy, the virus could pass through the placenta and infect the fetus and may consequently be associated with many cases of unexplained fetal and neonatal loss.


To date, a few studies have further suggested enterovirus infection during pregnancy as a risk factor for offspring developing type 1 diabetes and autoimmune thyroiditis during childhood and adolescence. Thus, documenting effects of gestational herpangina infection is essential for evaluating the fetal and maternal risk and designing appropriate clinical care for pregnant women affected by the disease. However, to date, no study has ever reported on pregnancy outcomes among women with herpangina during pregnancy.


In Taiwan, herpangina is common, with an epidemic occurring in 1998 recognized as the largest outbreak in Taiwan to date. In 1998, 405 severe cases of herpangina and 78 deaths were reported to the Center for Disease Control in Taiwan. Subsequent epidemics of herpangina came about every 2-3 years, which provided a unique opportunity to examine the effects of herpangina on birth outcomes.


The objective of this nationwide population-based study was to assess the risk for adverse pregnancy outcomes related to herpangina, specifically, low birthweight (LBW), preterm delivery, and small for gestational age (SGA), as compared with pregnant women without herpangina.


Materials and Methods


Database


The data used in this study came from 2 nationwide population-based data sets. The first was the Taiwan National Health Insurance Research Dataset (NHIRD), published by Taiwan National Health Research Institute. Taiwan began its National Health Insurance (NHI) program in 1995. Currently more than 22 million citizens, representing more than 98% of the Taiwanese population, are enrolled in this program. The NHIRD comprises all medical claims for enrollees covered under the program as well as registries of contracted medical facilities, board-certified physicians, and beneficiaries. Therefore, the NHIRD, 1 of the largest nationwide population-based data sets available, provides a unique opportunity to examine the risk of adverse pregnancy outcomes among women with herpangina.


The second data set was Taiwan’s birth certificate registry. The government in Taiwan mandates all births be registered, so the birth certificate data are accurate and comprehensive. The completeness and validity of Taiwan’s birth registry has been verified. Taiwan’s birth certificate registry includes data consisting of birth dates for both infants and their parents, gestational week at birth, infant birthweight, sex, parity, place of birth, parental educational levels, and maternal marital status.


These 2 data sets were linked by the mother’s and infant’s unique personal identification numbers with assistance from the Bureau of the NHI. All personal identifiers were encrypted by the Bureau of NHI before release to the researchers. Because the NHIRD consists of deidentified secondary data released to the public for research purposes, this study was exempt from full review by the internal review board.


Study sample


The study features a study cohort and a comparison cohort. A total of 242 pregnant women who had singleton live births between 2001 and 2003 in Taiwan (there were 473,529 pregnant women who had singleton live births during the study period) were identified as having ever visited ambulatory care centers for the treatment of herpangina (any International Classification of Diseases, Ninth Revision, Clinical Modification code 0740) during their pregnancies. If a mother had more than 1 singleton birth between 2001 and 2003, we included only the first 1 for the study sample, regardless of herpangina infection status.


The comparison group was extracted from the remaining 471,603 mothers. We randomly selected 1936 mothers (8 for every mother with herpangina, in accordance with principles proposed by Rothman and Hennessy et al ) and used the SAS statistical package (SAS Institute, Cary, NC) to match the study group in terms of age (<20, 20-24, 25-29, 30-34 and ≥35 years old) and the year of delivery. Ultimately, 2718 women were included in our study sample.


Variables of interest


The outcome variables of this study were all dichotomous and included LBW (<2500 vs ≥2500 g), preterm delivery (<37 weeks vs ≥37 weeks), and SGA (birthweight below the 10th percentile for gestational age). The independent variable of interest was whether a mother had been diagnosed with herpangina during the index pregnancy.


In this study, we also adjusted for the characteristics related to adverse pregnancy outcomes reported by previous studies in the regression modeling. These included factors relating to the mother (age, the highest educational level [elementary school or lower, junior high school, senior high school, college or above] and marital status ), the infant (sex and parity ), and monthly family income.


Monthly income was grouped into the following 4 categories: less than New Taiwan (NT) $15,000, NT$15,000-NT30,000, NT$30,001-NT50,000, NT$50,001 or greater (US$1.00 = NT$33.00 in 2003). In addition, comorbid chronic medical conditions that may increase the risk of adverse pregnancy outcomes, such as hypertension, diabetes, anemia, coronary heart disease (CHD), and hyperlipidemia, were also adjusted for in the regression modeling.


Statistical analysis


In this study, we used the SAS statistical package (version 8.2) to perform all analyses. The χ 2 tests were conducted to investigate the differences in the characteristics of mother and infant between mothers with herpangina and unaffected mothers. Conditional logistic regression analyses, which were conditioned on maternal age and the year of delivery, were performed to examine the risk of LBW, preterm birth, and SGA for mothers with herpangina and unaffected mothers, after adjusting for characteristics of the mother (age, the highest educational level, and marital status), infant (sex and parity) and monthly family income and diabetes, hypertension, anemia, CHD, and hyperlipidemia. A 2-sided P < .05 was considered statistically significant.




Results


Table 1 presents the distribution of characteristics of mothers and infants between mothers with herpangina and unaffected mothers. The mean age for the sampled patients was 28.9 years with an SD of 5.1 years. After matching for maternal age and the year of delivery, the χ 2 tests showed that there were significant differences in the monthly family income ( P = .009) and infant parity ( P < .001) between mothers with herpangina and unaffected mothers. No significant difference in the prevalence of comorbid chronic medical conditions (including hypertension, diabetes, anemia, CHD, and hyperlipidemia) was observed between these 2 groups of mothers.



TABLE 1

Comparisons of mothers with and without herpangina according to maternal and infant characteristics in Taiwan, 2001–2003 (n = 2178)




















































































































































































































































































































Variable Mothers with herpangina (n = 242) Mothers in comparison group (n = 1936) P value
Total n % Total n %
Maternal characteristics, age, y 1.000
<20 8 3.3 64 3.3
20-24 44 18.2 352 18.2
25-29 80 33.1 640 33.1
30-34 86 35.5 688 35.5
>34 24 9.9 192 9.9
Education level .331
Elementary school or lower 4 1.6 26 1.3
Junior high school 50 20.7 314 16.2
Senior high school 156 64.5 1306 67.5
College or above 32 13.2 290 15.0
Marital status .144
Married 238 98.4 1870 96.6
Other 4 1.6 66 3.4
Family monthly income < .001
Less than NT$15,000 60 24.8 650 33.6
NT$15,000-30,000 46 19.0 482 24.9
NT$30,001-50,000 82 33.9 506 26.1
More than NT$50,000 54 22.3 298 15.4
Diabetes .932
Yes 8 3.3 62 3.2
No 234 96.7 1874 96.8
Hypertension .903
Yes 4 1.6 30 1.6
No 238 98.4 1906 98.4
Anemia .412
Yes 8 3.3 86 4.4
No 234 96.7 1850 95.6
Coronary heart disease .132
Yes 4 1.6 14 0.7
No 238 98.4 1922 99.3
Hyperlipidemia .204
Yes 4 1.6 16 0.8
No 238 98.4 1920 99.2
Infant characteristics
Sex .832
Male 130 53.7 1026 53.0
Female 112 46.3 910 47.0
Parity < .001
1 66 27.3 994 51.4
2 124 51.2 630 32.5
≥3 52 21.5 312 16.1

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 7, 2017 | Posted by in GYNECOLOGY | Comments Off on Increased risk of adverse pregnancy outcomes among women affected by herpangina

Full access? Get Clinical Tree

Get Clinical Tree app for offline access